D-0289-2015 Class III Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-0289-2015 was initiated by Zydus Pharmaceuticals USA Inc on Sep 24, 2014 and is designated Class III. Reason for recall: Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules. The recall status is terminated (terminated Jun 21, 2017). Affected quantity: 63,648 Bottles.

Recall details

Product Type
Drugs
Report Date
Dec 10, 2014
Initiation Date
Sep 24, 2014
Termination Date
Jun 21, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
63,648 Bottles

Product description

BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only. Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA, Inc. NDC: 68382-248-01

Reason for recall

Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.

Distribution pattern

US Nationwide including Puerto Rico

Code information

Lot #: MM8555, Expiry: 09/14; Lot #: MM6604, Expiry: 09/14; Lot #: MM8551, Expiry: 09/14; Lot #: MM8552, Expiry: 09/14; Lot #: MM8553, Expiry: 09/14; Lot #: MM8554, Expiry: 09/14.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0289-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0289-2015. Report a data issue: hello@regdatalab.com.